V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320004985 | 320003363 | 1.79 | 53 | Palliative (P) | 2018-11-27 | 2018-12-12 | Trial Unspecified | N | Y | 320014959 | TRIAL |
| 320004986 | 320007274 | 1.58 | 53.1 | Curative (C) | 2018-04-25 | 2018-05-28 | Cisplatin | N | null | 320014965 | CISPLATIN |
| 320004990 | 320003372 | 1.58 | 71.9 | Disease modification (D) | null | 2015-08-05 | Cetuximab 7 day (>Cycle 2) | N | N | 320014998 | CETUXIMAB |
| 320004991 | 320003376 | 1.69 | 73 | Palliative (P) | 2015-04-23 | 2015-04-30 | Cetuximab 7 day (Cycle 1) | N | Y | 320015000 | CETUXIMAB |
| 320004992 | 320003376 | 1.75 | 81 | Palliative (P) | 2017-10-25 | 2017-10-25 | Carboplatin + Liposomal Doxorubicin | N | Y | 320015000 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004993 | 320003376 | 1.79 | 59.4 | Palliative (P) | 2014-03-03 | 2014-03-29 | Liposomal Doxorubicin (Caelyx) | 02 | Y | 320015000 | LIPOSOMAL DOXORUBICIN |
| 320004994 | 320003377 | 1.54 | 72 | null | 2015-09-01 | 2015-10-22 | Trial Unspecified | Y | N | 320015009 | TRIAL |
| 320004995 | 320003377 | 1.68 | 57.1 | Palliative (P) | 2014-11-10 | 2014-11-26 | LIPOSOMAL DOXORUBICIN | 02 | Y | 320015009 | LIPOSOMAL DOXORUBICIN |
| 320004996 | 320003379 | 1.7 | 70.2 | Palliative (P) | 2016-08-22 | 2016-08-24 | Carboplatin + Liposomal Doxorubicin | N | N | 320015035 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004997 | 320003379 | 1.68 | 117.4 | Palliative (P) | null | 2015-12-14 | Liposomal Doxorubicin 40mg/m2 | N | Y | 320015035 | LIPOSOMAL DOXORUBICIN |
| 320004998 | 320003381 | 1.78 | 76.7 | Palliative (P) | 2018-10-26 | 2018-10-29 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | null | 320015041 | NOT MATCHED |
| 320004999 | 320003382 | 1.54 | 53 | Palliative (P) | null | 2013-08-28 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 320015043 | LIPOSOMAL DOXORUBICIN |
| 320005000 | 320003382 | 1.71 | 66.8 | Palliative (P) | null | 2013-09-16 | GemCarbo Days 1+8 | 02 | N | 320015043 | GEMCARBO |
| 320005001 | 320003383 | 1.82 | 60 | Neo-adjuvant (N) | 2017-02-23 | 2017-06-17 | Trial Unspecified | N | N | 320015052 | TRIAL |
| 320005002 | 320006567 | 1.6 | 114.2 | Palliative (P) | 2014-04-28 | 2016-08-17 | GemCarbo Days 1+8 | Y | N | 320015061 | GEMCARBO |
| 320005003 | 320006567 | 1.66 | 73.6 | Palliative (P) | 2019-04-07 | 2019-04-07 | GEMCARBO | N | N | 320015061 | GEMCARBO |
| 320005004 | 320006567 | 1.68 | 65 | Palliative (P) | 2014-12-14 | 2014-12-26 | Trial Unspecified | N | N | 320015061 | TRIAL |
| 320005006 | 320003386 | 1.77 | 71.6 | Curative (C) | 2017-06-05 | 2017-08-12 | Trial Unspecified | N | Y | 320015076 | TRIAL |
| 320005007 | 320003386 | 1.86 | 95 | Palliative (P) | 2018-06-20 | 2018-06-21 | Trial Unspecified | 02 | N | 320015076 | TRIAL |
| 320005008 | 320007052 | 1.31 | null | Curative (C) | 2015-10-05 | 2015-11-03 | CETUXIMAB | N | N | 320015086 | CETUXIMAB |
| 320005009 | 320003387 | 1.57 | 74.3 | Palliative (P) | 2016-02-12 | 2016-02-20 | Carboplatin + Liposomal Doxorubicin | N | Y | 320015090 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005010 | 320003389 | 1.8 | 69.2 | Curative (C) | 2016-10-14 | 2016-10-18 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320015094 | CISPLATIN + RT |
| 320005011 | 320003390 | 1.66 | 8.1 | Palliative (P) | 2018-03-18 | 2018-04-01 | CETUXIMAB | N | N | 320015100 | CETUXIMAB |
| 320005012 | 320003391 | 1.64 | 74.3 | Palliative (P) | 2017-05-14 | 2017-06-12 | Liposomal Doxorubicin (Caelyx) | 2 | Y | 320015101 | LIPOSOMAL DOXORUBICIN |
| 320005013 | 320005545 | 1.7 | 72.5 | Adjuvant (A) | 2017-06-09 | 2017-06-24 | Trial Unspecified | N | Y | 320015104 | TRIAL |
| 320005014 | 320005545 | 1.73 | 85 | Palliative (P) | 2018-03-19 | 2018-03-29 | WT SIOP 2002 01 post op Vinc alone | 02 | N | 320015104 | NOT MATCHED |
| 320005015 | 320005545 | 1.78 | 108 | Curative (C) | 2015-01-13 | 2015-02-06 | CISPLATIN + RT | N | Y | 320015104 | CISPLATIN + RT |
| 320005016 | 320005545 | 1.54 | 82.3 | Palliative (P) | 2017-07-13 | 2017-07-27 | GemCarbo Days 1+8 | 02 | N | 320015104 | GEMCARBO |
| 320005017 | 320003392 | 1.75 | 48.5 | Curative (C) | 2014-10-23 | 2014-11-04 | Cisplatin + Radiotherapy | N | N | 320015117 | CISPLATIN + RT |
| 320005018 | 320006570 | 1.55 | 61 | Palliative (P) | 2016-12-08 | 2016-12-08 | null | N | null | 320015126 | NOT MATCHED |
| 320005019 | 320007054 | 1.74 | null | Disease modification (D) | 2017-08-16 | 2017-09-02 | Cetuximab 7 day (Cycle 1) | N | N | 320015127 | CETUXIMAB |
| 320005020 | 320003394 | 1.82 | 137 | Palliative (P) | 2015-08-16 | 2015-09-04 | CARBOPLATIN + GEMCITABINE | Y | null | 320015137 | GEMCARBO |
| 320005021 | 320003395 | 1.55 | 58.5 | Curative (C) | 2016-08-23 | 2016-10-05 | Cisplatin + Radiotherapy | N | N | 320015141 | CISPLATIN + RT |
| 320005022 | 320003396 | null | 74.3 | Palliative (P) | 2016-06-20 | 2016-06-20 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320015145 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005023 | 320003399 | null | 63.5 | null | 2018-05-08 | 2018-05-11 | GemCarbo Days 1+8 | N | Y | 320015146 | GEMCARBO |
| 320005024 | 320003399 | 1.69 | 55.4 | Palliative (P) | 2017-03-01 | 2017-03-01 | Trial Unspecified | N | N | 320015146 | TRIAL |
| 320005025 | 320003400 | 1.82 | null | Palliative (P) | 2017-05-20 | 2017-05-29 | CETUXIMAB | 02 | N | 320015153 | CETUXIMAB |
| 320005026 | 320003402 | 1.7 | 77.2 | Palliative (P) | 2015-06-05 | 2015-06-10 | Carboplatin + Liposomal Doxorubicin | N | N | 320015168 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005027 | 320003403 | 1.5 | 65.2 | Palliative (P) | 2017-01-14 | 2017-01-14 | Carboplatin + Liposomal Doxorubicin | 02 | Y | 320015174 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005028 | 320003404 | 1.7 | 83 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-23 | null | N | N | 320015174 | NOT MATCHED |
| 320005029 | 320003405 | 1.64 | 61 | null | 2017-02-13 | 2017-06-15 | Cisplatin | N | N | 320015183 | CISPLATIN |
| 320005030 | 320007278 | 1.85 | 103 | Neo-adjuvant (N) | 2016-07-07 | 2016-07-07 | CARBOPLATIN + GEMCITABINE | 02 | N | 320015197 | GEMCARBO |
| 320005031 | 320007278 | 1.78 | null | Adjuvant (A) | 2015-03-12 | 2015-03-12 | EW EuroEwing 2012 Arm B IE | 1 | N | 320015197 | TRIAL |
| 320005032 | 320003407 | 1.67 | 76.1 | Palliative (P) | 2018-05-16 | 2018-05-17 | Liposomal Doxorubicin 40mg/m2 | N | N | 320015206 | LIPOSOMAL DOXORUBICIN |
| 320005033 | 320003408 | 1.67 | null | Neo-adjuvant (N) | 2016-04-01 | 2016-05-09 | CETUXIMAB | N | N | 320015209 | CETUXIMAB |
| 320005034 | 320003409 | 1.59 | 53.45 | Palliative (P) | 2017-09-17 | 2017-09-21 | CISPLATIN + FLUOROURACIL | 02 | N | 320015214 | CISPLATIN + FLUOROURACIL |
| 320005035 | 320003411 | 1.68 | 109 | Palliative (P) | 2017-03-31 | 2017-04-05 | Liposomal Doxorubicin (Caelyx) | N | N | 320015223 | LIPOSOMAL DOXORUBICIN |
| 320005036 | 320003412 | 1.62 | 0 | Adjuvant (A) | 2016-08-01 | 2016-08-02 | Cisplatin + Radiotherapy | N | Y | 320015226 | CISPLATIN + RT |
| 320005037 | 320003413 | 1.79 | 93.35 | Adjuvant (A) | 2013-08-07 | 2013-09-04 | CETUXIMAB | 02 | Y | 320015227 | CETUXIMAB |
| 320005038 | 320003414 | 1.63 | 53 | Palliative (P) | 2017-10-04 | 2017-10-09 | Carboplatin + Liposomal Doxorubicin | 2 | null | 320015234 | CARBOPLATIN + LIPOSOMAL DOX |